NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
4.070
-0.960 (-19.09%)
At close: Sep 8, 2026, 4:00 PM EDT
4.126
+0.056 (1.38%)
After-hours: Sep 8, 2026, 5:38 PM EDT
NTHI Revenue
NeOnc Technologies Holdings had revenue of $39.99K in the twelve months ending June 30, 2026, up 99.95% year-over-year. In the year 2025, NeOnc Technologies Holdings had annual revenue of $39.99K, down -51.82%.
Revenue (ttm)
$39.99K
Revenue Growth
+99.95%
P/S Ratio
2,529.81
Revenue / Employee
$7,998
Employees
5
Market Cap
101.17M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 39.99K | -43.01K | -51.82% |
| Dec 31, 2024 | 83.00K | 12.54K | 17.79% |
| Dec 31, 2023 | 70.46K | 50.46K | 252.31% |
| Dec 31, 2022 | 20.00K | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
NTHI News
- 9 hours ago - NeOnc' Phase 2 Data Could Put Cancer on the Ropes - GlobeNewsWire
- 11 days ago - NeOnc's Phase 2A Success Could Set the Stage for Something Much Bigger - GlobeNewsWire
- 13 days ago - NeOnc's Clinical Story Is Now the Main Event - GlobeNewsWire
- 21 days ago - NeOnc Technologies- Talk Is Cheap, Insider Buying Isn't - GlobeNewsWire
- 22 days ago - These Nasdaq Stories Are Heating Up - GlobeNewsWire
- 22 days ago - NTHI's Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results - GlobeNewsWire
- 22 days ago - NeOnc says Phase 2a portion of NEO100-01 study met primary endpoint - TheFly
- 25 days ago - NeOnc Technologies Holdings Transcript: AGM 2026 - Transcripts